Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pacific Pharmaceuticals in-licenses cancer chemosensitizer

March 24, 1998

NaPro and Ivax terminate paclitaxel agreement

March 24, 1998

Gene discovery technologies available for licensing from GenQuest

March 24, 1998

Mda genes and platform technology available for licensing from GenQuest

March 24, 1998

GenQuest offers antibodies and related technology for licensing

March 24, 1998

Mitsui Toatsu prepares new thymidine phosphorylase inhibitors

March 24, 1998

GenQuest offers prostate cancer-related genes for licensing

March 24, 1998

BMS prepares new paclitaxel analogues

March 24, 1998

Prenyl transferase inhibitors from Biomeasure

March 24, 1998

FDA advisory committee recommends approval of capecitabine

March 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...